2.02
price up icon15.06%   0.26
 
loading
Pulmonx Corp stock is traded at $2.02, with a volume of 1.89M. It is up +15.06% in the last 24 hours and up +25.00% over the past month. Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
See More
Previous Close:
$1.76
Open:
$1.76
24h Volume:
1.89M
Relative Volume:
0.82
Market Cap:
$82.71M
Revenue:
$68.68M
Net Income/Loss:
$-60.84M
P/E Ratio:
-1.2625
EPS:
-1.6
Net Cash Flow:
$-38.42M
1W Performance:
+23.48%
1M Performance:
+25.00%
6M Performance:
-58.07%
1Y Performance:
-67.60%
1-Day Range:
Value
$1.74
$2.10
1-Week Range:
Value
$1.56
$2.89
52-Week Range:
Value
$1.47
$9.37

Pulmonx Corp Stock (LUNG) Company Profile

Name
Name
Pulmonx Corp
Name
Phone
650-364-0400
Name
Address
700 CHESAPEAKE DRIVE, REDWOOD CITY
Name
Employee
291
Name
Twitter
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
LUNG's Discussions on Twitter

Compare LUNG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
LUNG
Pulmonx Corp
2.0299 71.71M 68.68M -60.84M -38.42M -1.60
Medical Devices icon
ABT
Abbott Laboratories
123.69 216.79B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
BSX
Boston Scientific Corp
101.05 149.02B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
357.75 141.06B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
91.04 116.68B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
83.01 49.01B 5.69B 1.41B 577.90M 6.9828

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-31-25 Downgrade Piper Sandler Overweight → Neutral
Mar-10-25 Initiated D. Boral Capital Buy
Dec-11-24 Downgrade Citigroup Buy → Neutral
Jun-04-24 Initiated Lake Street Buy
Feb-23-24 Downgrade Wells Fargo Overweight → Equal Weight
Sep-05-23 Initiated Craig Hallum Buy
Feb-27-23 Upgrade Wells Fargo Equal Weight → Overweight
Jan-03-23 Downgrade BofA Securities Neutral → Underperform
Dec-12-22 Upgrade Citigroup Neutral → Buy
Jul-11-22 Downgrade Citigroup Buy → Neutral
Mar-02-22 Resumed BofA Securities Neutral
Dec-08-21 Upgrade Piper Sandler Neutral → Overweight
Apr-01-21 Initiated Citigroup Buy
Mar-25-21 Initiated Piper Sandler Neutral
Mar-10-21 Upgrade BofA Securities Neutral → Buy
Jan-04-21 Downgrade BofA Securities Buy → Neutral
Oct-26-20 Initiated BofA Securities Buy
Oct-26-20 Initiated Canaccord Genuity Buy
Oct-26-20 Initiated Morgan Stanley Equal-Weight
Oct-26-20 Initiated Stifel Buy
Oct-26-20 Initiated Wells Fargo Equal Weight
View All

Pulmonx Corp Stock (LUNG) Latest News

pulisher
05:46 AM

Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? - Insider Monkey

05:46 AM
pulisher
12:55 PM

Is Pulmonx Corporation reversing from oversold territoryWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com

12:55 PM
pulisher
12:31 PM

Historical volatility pattern of Pulmonx Corporation visualizedChart Signals & High Accuracy Swing Trade Signals - newser.com

12:31 PM
pulisher
Oct 29, 2025

Why Pulmonx Corporation stock remains on watchlistsJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is this a good reentry point in Pulmonx CorporationJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Pulmonx (NASDAQ:LUNG) Given New $14.00 Price Target at D. Boral Capital - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Pulmonx (LUNG) Anticipates Q3 Revenue of $21.5 Million - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

What hedge fund activity signals for Pulmonx Corporation stockRecession Risk & Daily Profit Maximizing Tips - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Tick level data insight on Pulmonx Corporation volatilityMarket Activity Summary & Entry Point Strategy Guides - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Lake Street Lowers Price Target for Pulmonx (LUNG) Amidst Mainta - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

LUNG’s Surprise Revenue Surge: Key Factors - StocksToTrade

Oct 28, 2025
pulisher
Oct 28, 2025

Pulmonx brings back former CEO amid leadership shakeup - Investing.com India

Oct 28, 2025
pulisher
Oct 28, 2025

Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Exp - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Canaccord Genuity reiterates Buy rating on Pulmonx stock amid leadership changes - Investing.com Nigeria

Oct 28, 2025
pulisher
Oct 28, 2025

Using data filters to optimize entry into Pulmonx CorporationQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Using Python tools to backtest Pulmonx Corporation strategiesDip Buying & Fast Gain Stock Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

D. Boral Capital Maintains Pulmonx (LUNG) Buy Recommendation - Nasdaq

Oct 28, 2025
pulisher
Oct 28, 2025

Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Oct 28, 2025
pulisher
Oct 28, 2025

Analyst Lowers Price Target for Pulmonx (LUNG) While Maintaining Buy Rating | LUNG Stock News - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Pulmonx brings back former CEO amid leadership shakeup By Investing.com - Investing.com Australia

Oct 28, 2025
pulisher
Oct 28, 2025

Will Pulmonx Corporation stock maintain momentum in 2025Weekly Gains Report & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Technical signs of recovery in Pulmonx CorporationWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How Pulmonx Corporation stock compares to market leaders2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Healthcare Rally: Pulmonx, UHS, And X4 Lead After-Hours Gains Amid Strategic Updates - Nasdaq

Oct 28, 2025
pulisher
Oct 27, 2025

What catalysts could drive Pulmonx Corporation stock higherMarket Volume Summary & Fast Exit/Entry Strategy Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Visualizing Pulmonx Corporation stock with heatmaps2025 Market Outlook & Safe Capital Growth Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Pulmonx Corp (LUNG) Q3 2025 Earnings: Revenue Surpasses Estimates at $21.5 Million - GuruFocus

Oct 27, 2025
pulisher
Oct 27, 2025

LUNG to Discuss Q3 2025 Results and Annual Outlook in November C - GuruFocus

Oct 27, 2025
pulisher
Oct 27, 2025

Pulmonx Announces Leadership Changes with New CEO - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Pulmonx announces management transition and preliminary third quarter 2025 revenue reschedules third quarter 2025 earnings call to November 12, 2025 - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Pulmonx Announces Management Transition And Preliminary Third Quarter 2025 Revenue Reschedules Third Quarter 2025 Earnings Call To November 12, 2025 - TradingView

Oct 27, 2025
pulisher
Oct 27, 2025

Pulmonx Corporation Announces Leadership Transition and Preliminary Third Quarter 2025 Revenue Estimates - Quiver Quantitative

Oct 27, 2025
pulisher
Oct 27, 2025

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Pulmonx Corporation Announces CEO Changes, Effective October 27, 2025 - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Pulmonx (Nasdaq: LUNG) reappoints Glen French as CEO; preliminary Q3 revenue ~$21.5M - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Real time social sentiment graph for Pulmonx CorporationPortfolio Growth Summary & High Conviction Buy Zone Picks - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Can Pulmonx Corporation stock withstand economic slowdownTrade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com

Oct 27, 2025

Pulmonx Corp Stock (LUNG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Pulmonx Corp Stock (LUNG) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Joshi Mehul
Chief Financial Officer & PAO
Sep 02 '25
Sale
1.60
7,936
12,698
208,489
Rose Geoffrey Beran
CHIEF COMMERCIAL OFFICER
Sep 02 '25
Sale
1.60
6,543
10,469
379,788
Lehman David Aaron
GENERAL COUNSEL
Sep 02 '25
Sale
1.60
9,769
15,630
263,270
Ferrari Richard
Director
Jun 12 '25
Sale
3.16
8,000
25,280
87,024
$315.78
price up icon 1.22%
$58.99
price down icon 13.45%
medical_devices STE
$236.09
price down icon 0.18%
medical_devices PHG
$27.41
price up icon 0.53%
$74.64
price down icon 0.49%
medical_devices EW
$82.91
price down icon 0.66%
Cap:     |  Volume (24h):